Mana.bio
Mana.bio develops artificial intelligence–based platforms for drug delivery using lipid nanoparticles (LNPs). The company combines machine learning with nanotechnology to design, test, and refine LNP formulations through computational modeling and laboratory validation. Its technology focuses on extrahepatic tissue targeting and includes research on lung-targeted delivery and safety improvements through predictive modeling. Mana.bio has introduced ChatLNP, a tool that supports literature analysis, property prediction, and formulation optimization. The platform integrates experimental results with public data to enhance model accuracy and broaden its design capabilities for gene therapy and RNA-based medicines.
Tech Stack (11 technologies)
Frequently Asked Questions
What technologies does Mana.bio use?+
Mana.bio uses 11 technologies including Sentry, Wix, React.
What industry is Mana.bio in?+
Mana.bio operates in the Artificial Intelligence (AI) industry.
Where is Mana.bio based?+
Mana.bio is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026